معرفی
Clara Fonteneau is an Associate Research Scientist in the Department of Psychiatry at Yale University, affiliated with the Anticevic Lab and Cho Lab within the Division of Neurocognition, Neurocomputation & Neurogenetics (N3). She holds a PhD in Neuroscience from the University of Lyon (2018), where her thesis focused on transcranial direct current stimulation (tDCS) mechanisms and dopaminergic system interactions using multimodal imaging. At Yale, her research emphasizes translational neuroimaging approaches to study neuropsychiatric disorders, particularly exploring common mechanisms across disorders and individual variability in brain-behavior relationships.
Her work integrates computational models with multimodal neuroimaging techniques to investigate conditions like schizophrenia and psychosis. Notable collaborations include the Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ), a global cohort study targeting clinical high-risk populations. Fonteneau’s studies also examine ketamine’s effects on brain connectivity and individual responses, alongside dopamine-related neurostimulation therapies.
Fonteneau’s publications highlight reproducible brain state dynamics, neurobiological mechanisms in psychosis, and pharmacological trial methodologies. Her research bridges basic neuroscience with clinical applications, aiming to advance diagnostic and therapeutic strategies for neuropsychiatric conditions.
